Skip to main content

DNA Methylation in Pancreatic Cancer: Protocols for the Isolation of DNA and Bisulfite Modification

  • Protocol
  • First Online:
Book cover Cancer Epigenetics

Part of the book series: Methods in Molecular Biology ((MIMB,volume 863))

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive tumor and still remains a challenge for its lack of effective therapeutic strategies, which is due to the late diagnosis of this disease. Methylation markers might improve early detection and surveillance of PDAC. Furthermore, analysis of hypermethylation in the tumor tissue might help to identify new targets for therapeutic intervention and improve the understanding of the pathophysiological changes occurring in pancreatic cancer. Methylation specific PCR is the method of choice if a small number of genes will be tested in a larger set of patient samples. After DNA isolation by standard procedure, the DNA is then modified using sodium bisulfite. This DNA can then be used in qualitative and quantitative PCR assays.

KB and MH contributed equallyl.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jemal, A., Siegel, R., Xu, J., and Ward, E. (2010) Cancer statistics, 2010. CA Cancer J Clin 60, 277–300.

    Article  PubMed  Google Scholar 

  2. Schneider, G., Siveke, J.T., Eckel, F., and Schmid, R.M. (2005) Pancreatic cancer: basic and clinical aspects. Gastroenterology 128, 1606–1625.

    Article  PubMed  CAS  Google Scholar 

  3. Kulis, M. and Esteller, M. (2010) DNA methylation and cancer. Adv Genet 70, 27–56.

    Article  PubMed  Google Scholar 

  4. Nakhasi, H.L., Lynch, K.R., Dolan, K.P., Unterman, R.D., and Feigelson P. (1981) Covalent modification and repressed transcription of a gene in hepatoma cells. Proc Natl Acad Sci USA 78, 834–837.

    Article  PubMed  CAS  Google Scholar 

  5. Lofton-Day, C., Model, F., Devos, T., Tetzner, R., Distler, J., Schuster, M. et al (2008) DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 54, 414–423.

    Article  PubMed  CAS  Google Scholar 

  6. Tan, A.C., Jimeno, A., Lin, S.H., Wheelhouse, J., Chan, F., Solomon, A. et al (2009) Characterizing DNA methylation patterns in pancreatic cancer genome. Mol Oncol 3, 425–438.

    Article  PubMed  CAS  Google Scholar 

  7. Wehrum, D., Grutzmann, R., Hennig, M., Saeger, H.D., and Pilarsky, C. (2008) Recent patents concerning diagnostic and therapeutic applications of aberrantly methylated sequences in pancreatic cancer. Recent Pat DNA Gene Seq 2, 97–106.

    Article  PubMed  CAS  Google Scholar 

  8. Kuroki, T., Tajima, Y., and Kanematsu, T. (2004) Role of hypermethylation on carcinogenesis in the pancreas. Surg Today 34, 981–986.

    Article  PubMed  CAS  Google Scholar 

  9. Wright, D.K. and Manos, M.M. (1990). Sample preparation from paraffin-embedded tissues. In: Innis M.A., Gelfont D.H., Sninsky J.J. and White T.J. (eds). PCR Protocols: A guide to methods and applications. Academic Press, San Diego. pp 153–158.

    Google Scholar 

  10. Hong, S.M., Kelly, D., Griffith, M., Omura, N., Li, A., Li, C.P. et al. (2008). Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas. Mod Pathol 12, 1499–1507.

    Article  Google Scholar 

  11. Noetzel, E., Veeck, J., Niederacher, D., Galm, O., Horn, F., Hartmann, A. et al. (2008) Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer. BMC Cancer 8, 154.

    Article  PubMed  Google Scholar 

  12. Okami, J., Simeone, D.M., and Logsdon, C.D. (2004) Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. Cancer Res 64, 5338–5346.

    Article  PubMed  CAS  Google Scholar 

  13. Dunn, J.R., Panutsopulos, D., Shaw, M.W. Heighway, J., Dormer, R., Salmo, E.N. et al. (2004) METH-2 silencing and promoter hypermethylation in NSCLC. Br J Cancer 91, 1149–1154.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

I am grateful to Beatrix Jahnke for performing DNA isolation and bisulfite modification in our lab. Thanks also to Alfred E. Neumann for fruitful discussions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christian Pilarsky .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Biewusch, K., Heyne, M., Grützmann, R., Pilarsky, C. (2012). DNA Methylation in Pancreatic Cancer: Protocols for the Isolation of DNA and Bisulfite Modification. In: Dumitrescu, R., Verma, M. (eds) Cancer Epigenetics. Methods in Molecular Biology, vol 863. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-612-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-612-8_16

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-611-1

  • Online ISBN: 978-1-61779-612-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics